The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease

Expert Reviews in Molecular Medicine

Volumn 11, Issue , 2009, Pages

  Yan, Shi Fang ^a   Ramasamy, Ravichandran ^a   Schmidt, Ann Marie ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ANIMAL; CARDIOVASCULAR DISEASE; HUMAN; INFLAMMATION; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; REGENERATION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION; OXIDATIVE STRESS; RECEPTORS, IMMUNOLOGIC; REGENERATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 65349167787     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S146239940900101X     Document Type: Review

References (91)

1. Stevens, V.J. et al. (1977) Nonenzymatic glycosylation of hemoglobin. Journal of Biological Chemistry 252, 2998-3002 (Pubitemid 8096462)
2. Day, J. et al. (1979) Nonenzymatic glycosylation of rat albumin. Journal of Biological Chemistry 254, 9394-9400
3. Schnider, S.L. and Kohn, R.R. (1980) Glucosylation of human collagen in aging and diabetes mellitus. Journal of Clinical Investigation 66, 1179-1181 (Pubitemid 11233822)
4. Sensi, M.S. et al. (1991) Advanced nonenzymatic glycation endproducts (AGEs): their relevance to aging and the pathogenesis of late diabetic complications. Diabetes Research 16, 1-9
5. Brownlee, M. (1992) Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15, 1835-1843
6. Miyata, T. et al. (1996) Pathophysiology of advanced glycation endproducts in renal failure. Nephrology Dialysis Transplantation 11, 27-30 (Pubitemid 27062907)
7. Dawnay,A. and Millar, D.J. (1998) The pathogenesis and consequences of AGE formation in uraemia and its treatment. Cellular and Molecular Biology (Noisy-le-grand) 44, 1081-1094
8. Sakata, N. et al. (1995) Nonenzymatic glycation and extractability of collagen in human atherosclerotic plaques. Atherosclerosis 116, 63-75
9. Mulder, D.J. et al. (2006) Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence and limitations. Diabetes Technology and Therapeutics 8, 523-535 (Pubitemid 44946877)
10. Münch, G. et al. (1997) Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. European Journal of Clinical Chemistry and Clinical Biochemistry 35, 669-677
11. Matsumoto, T. et al. (2007) Measurement of advanced glycation endproducts in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non-invasive methods. Rheumatology International 28, 157-160 (Pubitemid 350105869)
12. De Leeuw, K. et al. (2007) Accumulation of advanced glycation end products in patients with systemic lupus erythematous. Rheumatology (Oxford) 46, 1551-1556
13. Charney, D.I. et al. (1993) Atherosclerosis in chronic renal failure. Current Opinion in Nephrology and Hypertension 2, 876-882
14. Farhey, Y. and Hess, E.V. (1997) Accelerated atherosclerosis and coronary diseases in SLE. Lupus 6, 572-577 (Pubitemid 27406160)
15. Bucciarelli, L.G. et al. (2006) Receptor for advanced glycation endproducts: key modulator of myocardial ischemic injury. Circulation 113, 1226-1234
16. Takizawa, S. et al. (2007) A novel inhibitor of advanced glycation end endoplasmic reticulum stress reduces infarct volume in rat focal cerebral ischemia. Brain Research 1183, 124-137 (Pubitemid 350088683)
17. Aleshin, A. et al. (2008) RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model. American Journal of Physiology - Heart and Circulatory Physiology 294, H1823-H1832 (Pubitemid 351490612)
18. Bucciarelli, L.G. et al. (2008) RAGE and modulation of ischemic injury in the diabetic myocardium. Diabetes 57, 1941-1951
19. Schmidt, A.M. et al. (1992) Isolation and characterization of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface. Journal of Biological Chemistry 267, 14987-14997
20. Neeper, M. et al. (1992) Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. Journal of Biological Chemistry 267, 14998-15004
21. Horiuchi, S., Sakamoto, Y. and Sakai, M. (2003) Scavenger receptors for oxidized and glycated proteins. Amino Acids 25, 283-292 (Pubitemid 38041266)
22. Ohgami, N. et al. (2002) CD36 serves a receptor for advanced glycation endproducts (AGEs). Journal of Diabetes and its Complications 16, 56-59 (Pubitemid 34168502)
23. Li, Y.M. et al. (1996) Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80 K-H membrane proteins. Proceedings of the National Academy of Sciences of the United States of America 93, 11047-11052
24. Lu, C. et al. (2004) Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. Proceedings of the National Academy of Sciences of the United States of America 101, 11767-11772 (Pubitemid 39099304)
25. McFarlane, S. et al. (2005) Characterization of the advanced glycation endproduct receptor complex in the retinal pigment epithelium. British Journal of Ophthalmology 89, 107-112 (Pubitemid 40040249)
26. Taguchi, A. et al. (2000) Blockade of amphoterin/RAGE signalling suppresses tumor growth and metastases. Nature 405, 354-360 (Pubitemid 30337069)
27. Lander,H.M. et al. (1997) Activation of the receptor for advanced glycation endproducts triggers a p21(ras)- dependentmitogen-activated protein kinase pathway regulated by oxidant stress. Journal of Biological Chemistry 272, 17810-17814 (Pubitemid 27311222)
28. Marsche, G. et al. (2007) Hypochlorite-modified albumin colocalizes with RAGE in the artery wall and promotes MCP-1 expression via the RAGE-ERK 1/2 MAP-kinase pathway. The FASEB Journal 21, 1145-1152 (Pubitemid 46495704)
29. Zeng, S. et al. (2004) Blockade of receptor for advanced glycation endproducts (RAGE) attenuates ischemia and reperfusion injury in the liver in mice. Hepatology 39, 422-432 (Pubitemid 38222183)
30. Reddy, M.A. et al. (2006) Key role of Src kinase in S100b-induced activation of the receptor for advanced glycation endproducts in vascular smooth muscle cells. Journal of Biological Chemistry 281, 13685-13693 (Pubitemid 43855284)
31. Sakaguchi, T. et al. (2003) Arterial restenosis: central role of RAGE-dependent neointimal expansion. Journal of Clinical Investigation 111, 959-972 (Pubitemid 36397472)
32. Bianchi, R. et al. (2007) S100b binding to RAGE in microglia stimulates cox-2 expression. Journal of Leukocyte Biology 81, 108-118 (Pubitemid 46021259)
33. Fukami, K. et al. (2004) AGEs activate mesangial TGF-beta-Smadsignaling via an angiotensin II type 1 receptor interaction. Kidney International 66, 2137-2147 (Pubitemid 41115277)
34. Vincent, A.M. et al. (2007) Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148, 548-558 (Pubitemid 46143159)
35. Yan, S.D. et al. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. Journal of Biological Chemistry 269, 9889-9897 (Pubitemid 24196599)
36. Huttunen, H.J., Kuja-Panula, J. and Rauvala, H. (2002) Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation. Journal of Biological Chemistry 277, 38635-38646 (Pubitemid 35154724)
37. Chang, J.S. et al. (2008) Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products. Circulation Research 102, 905-913 (Pubitemid 351591549)
38. Hofmann, M.A. et al. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889-901 (Pubitemid 29375048)
39. Yan, S.D. et al. (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691 (Pubitemid 26282167)
40. Arancio, O. et al. (2004) RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice. EMBO Journal 23, 4096-4105 (Pubitemid 39472430)
41. Chavakis, T. et al. (2003) The Pattern Recognition Receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. Journal of Experimental Medicine 198, 1507-1515 (Pubitemid 37467165)
42. Brett, J. et al. (1993) Tissue distribution of the receptor for advanced glycation endproducts (RAGE): expression in smooth muscle, cardiac myocytes, and neural tissue in addition to the vasculature. American Journal of Pathology 143, 1699-1712
43. Tanji, N. et al. (2000) The expression of Advanced Glycation Endproducts and their cellular receptor RAGE in diabetic nephropathy and non-diabetic renal disease. Journal of the American Society of Nephrology 11, 1656-1666
44. Oimomi, M. et al. (1989) Age- and diabetes-accelerated glycation in the human aorta. Archives of Gerontology and Geriatrics 8, 123-127 (Pubitemid 19078140)
45. Burke, A.P. et al. (2004) Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmorten study. Arteriosclerosis, Thrombosis, and Vascular Biology 24, 1266-1271 (Pubitemid 38880019)
46. Inoue, K. et al. (2007) HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. Cardiovascular Pathology 16, 136-143 (Pubitemid 46729668)
47. Kalinina, N. et al. (2004) Increased expression of the DNA binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arteriosclerosis, Thrombosis, and Vascular Biology 24, 2320-2325 (Pubitemid 39658036)
48. Park, L. et al. (1998) Suppression of accelerated diabetic atherosclerosis by soluble receptor for AGE (sRAGE). Nature Med 4, 1025-1031 (Pubitemid 28417334)
49. Kislinger, T. et al. (2001) RAGE mediates inflammation and enhanced expression of tissue factor in the vasculature of diabetic apolipoprotein E null mice. Arteriosclerosis, Thrombosis, and Vascular Biology 21, 905-910 (Pubitemid 34168644)
50. Bucciarelli, L.G. et al. (2002) RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E null mice. Circulation 106, 2827-2835 (Pubitemid 35396983)
51. Wendt, T. et al. (2006) RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis 185, 70-77 (Pubitemid 43117552)
52. Soro-Paavonen, A. et al. (2008) Receptor for advanced glycation endproducts (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 57, 2461-2469
53. Harja, E. et al. (2008) Vascular and inflammatory stresses mediate atherosclerosis via RAGE in apo E deficient mice. Journal of Clinical Investigation 118, 183-194
54. Roy, H. et al. (2006) VEGF-A, VEGF-D, VEGF-receptor-1, VEGF-receptor-2, NF-kB and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits. The FASEB Journal 20, 2159-2161
55. Schmidt, A.M. et al. (1993) Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. Journal of Clinical Investigation 91, 2155-2168 (Pubitemid 23141492)
56. Kislinger, T. et al. (1999) N-ε (carboxymethyl)lysine modifications of proteins are ligands for RAGE that activate cell signalling pathways and modulate gene expression. Journal of Biological Chemistry 274, 31740-31749
57. Rouhiainen, A. et al. (2004) Regulation of monocyte migration by amphoterin. Blood 104, 1174-1182
58. Isoda, K. et al. (2008) Glycated LDL increased monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1 mediated chemotaxis. Atherosclerosis 198, 307-312
59. Isoda, K. et al. (2007) AGE-BSA decreases ABCG1 expression and reduces macrophage cholesterol efflux to HDL. Atherosclerosis 192, 298-304 (Pubitemid 46726331)
60. Ichikawa, K. et al. (1998) Advanced glycosylation endproducts induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients. Atherosclerosis 136, 281-287 (Pubitemid 28133417)
61. Ding, Y. et al. (2007) Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus. Journal of Immunology 179, 647-654 (Pubitemid 46986583)
62. Shaw, S.S. et al. (2003) S100b-RAGE mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2. Diabetes 52, 2381-2388 (Pubitemid 37059510)
63. Yoon, Y.W. et al. (2008) Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy. Experimental and Molecular Medicine 31, 398-406
64. Wu, S. et al. (2008) Involvement of Na+/H+exchanger in advanced end products-induced proliferation of vascular smooth muscle cell. Biochemical and Biophysical Research Communications 375, 384-389
65. De Oliveira, S.C. et al. (2008) Modulation of CD36 protein expression by AGEs and insulin in aortic VSMCs from diabetic and non-diabetic rats. Nutrition, Metabolism and Cardiovascular Diseases 18, 23-30
66. Zhou, Z. et al. (2003) Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation 107, 2238-2243 (Pubitemid 36547219)
67. Hartog, J.W.L. et al. (2007) Advanced glycation end products and heart failure: pathophysiology of clinical implications. European Journal of Heart Failure 9, 1146-1155 (Pubitemid 350138497)
68. Koyama, Y. et al. (2007) High serum level of pentosidine, an advanced glycation endproduct (AGE), is a risk factor of patients with heart failure. Journal of Cardiac Failure 13, 199-206 (Pubitemid 46590033)
69. Hartog, J.W. et al. (2007) clinical and prognostic value of advanced glycation end products in chronic heart failure. European Heart Journal 28, 2879-2885 (Pubitemid 350233041)
70. Van Heerebeek, L. et al. (2008) Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 117, 43-51 (Pubitemid 350291180)
71. Koyama, Y. et al. (2008) Soluble receptor for advanced glycation endproducts (RAGE) is a prognostic factor for heart failure. Journal of Cardiac Failure 14, 133-198
72. Andrassy,M. et al. (2008) High mobility group box 1 in ischemia-reperfusion injury of the heart. Circulation 117, 3216-3226
73. Park, J.S. et al. (2004) Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. Journal of Biological Chemistry 279, 7370-7377 (Pubitemid 38294612)
74. Tsoporis, J.N. et al. (2005) S100b expression modulates left ventricular remodeling after myocardial infarction in mice. Circulation 111, 598-606 (Pubitemid 40216487)
75. Norton, G.R., Candy, G. andWoodiwiss, A.J. (1996) Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats. Circulation 93, 1905-1912 (Pubitemid 26154042)
76. Asif, M. et al. (2000) An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proceedings of the National Academy of Sciences of the United States of America 97, 2809-2813 (Pubitemid 30159253)
77. Little, W.C. et al. (2005) The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure. Journal of Cardiac Failure 11, 191-195 (Pubitemid 40462421)
78. Thohan, V. et al. (2005) Improvements in diastolic function among patients with advanced systolic heart failure utilizing alagebrium (an oral advanced glycation end-product cross-link breaker). Circulation 112, 2620-2647
79. Liu, J. et al. (2003) Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart. American Journal of Physiology - Heart and Circulatory Physiology 285, H2587-H2591 (Pubitemid 37443077)
80. Vaitkevicius, M. et al. (2001) A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proceedings of the National Academy of Sciences of the United States of America 98, 1171-1175
81. Cheng, G. et al. (2005) C16, a novel advanced glycation endproduct breaker, restores cardiovascular dysfunction in experimental diabetic rats. Acta Pharmacologica Sinica 26, 1460-1466 (Pubitemid 41789534)
82. Petrova, R. et al. (2002) Advanced glycation endproduct induced calcium handling impairment in mouse cardiac myocytes. Journal of Molecular and Cellular Cardiology 34, 1425-1431 (Pubitemid 35244419)
83. Xie, J. et al. (2007) Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. Journal of Biological Chemistry 282, 4218-4231 (Pubitemid 47084493)
84. Dattilo, B.M. et al. (2007) The extracellular region of the receptor for advanced glycation endproducts is composed of two independent structural units. Biochemistry 46, 6957-6970 (Pubitemid 46906424)
85. Leclerc, E. et al. (2007) S100b and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycated end products) immunoglobulin domains. Journal of Biological Chemistry 282, 31317-31331 (Pubitemid 350044892)
86. + cell proliferation and differentiation. Circulation Research 97, 73-83
87. Ramasamy, R., Yan, S.F. and Schmidt, A.M. (2008) Stopping the primal RAGE reaction in myocardial infarction: capturing adaptive responses to heal the heart? Circulation 117, 3165-3167
88. Moser, B. et al. (2007) Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo. Journal of Immunology 179, 8051-8058
89. Rong, L.L. et al. (2004) Antagonism of RAGE suppresses nerve regeneration. The FASEB Journal 18, 1812-1817
90. Rong, L.L. et al. (2004) RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways. The FASEB Journal 18, 1818-1825
91. Goova, M.T. et al. (2001) Blockade of receptor for advanced glycation endproducts restores effective wound healing in diabetic mice. American Journal of Pathology 159, 5130525